Healthcare Trust of America, In (NYSE:HTA):
Healthcare Trust of America Closes Over $2.6 Billion in 2Q Investments and Raises $2.9 Billion of Capital.
The company is trading up from yesterday’s close of $29.51.
Healthcare Trust of America, In declared a dividend for shareholders that was paid on Tue Jul 11, 2017. The dividend was $0.300 per share for the quarter or $1.20 annualized. This dividend represents a yield of $3.98. The ex-dividend date was Thursday the 6th of April 2017.
Healthcare Trust of America, Inc., launched on April 20, 2006, is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations. As of December 31, 2016, the Business’s portfolio consisted of approximately 17.7 million square feet of gross leasable area. As of December 31, 2016, the Business’s portfolio included MOBs, such as single-tenant and multi-tenant, and other healthcare facilities, such as hospitals and senior care. As of December 31, 2016, the Business’s portfolio had 355 buildings located in 31 states..
Company chares are trading at $29.80 slightly below the 50 day moving average which is $31.54 and which is marginally lower than the 200 day moving average of $30.70. The 50 day moving average moved down $-1.69 and the 200 day average went down $-0.85 or -2.77%.
The company’s P/E ratio is 87.79 and the market cap is 4.29B. In the last earnings report the EPS was $0.34 and is expected to be $0.30 for the current year with 143,841,000 shares outstanding. Next quarter’s EPS is expected be $0.03 and the next full year EPS is projected to be $0.15.
Several ratings analysts have issued ratings on HTA. On June 20 the stock rating was upgraded from “Market Perform” to “Outperform” in a report from BMO Capital. On November 7 the company was upgraded to “Outperform” from “” in a report issued by Raymond James.
On August 25, 2016 BTIG Research added the stock to its research portfolio with an initial rating of “Buy” and projecting a price target of $37.00. SunTrust Robinson Humphrey initiated coverage on the stock by announcing an initial rating of “Buy”.
On January 5 analysts at Oppenheimer started coverage giving it an initial rating of “Outperform” and establishing a price target of $31.00. Equity analyst Morgan Stanley starting coverage on the stock setting a rating of “Equal-weight”.Advertisement